Loading...
PD-1 inhibitors: Do they have a future in the treatment of glioblastoma?
Glioblastoma (WHO grade IV glioma) is the most common malignant primary brain tumor in adults. Survival has remained largely static for decades, despite significant efforts to develop new effective therapies. Immunotherapy, and especially immune checkpoint inhibitors and programmed cell death (PD)-1...
Saved in:
| Published in: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7682636/ https://ncbi.nlm.nih.gov/pubmed/32527943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-1135 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|